B. Lau
Statistics and Probability · with Auwaerter · 2009–2020
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Statistics and Probability — 5 citations into it
Whom B. Lau trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts B. Lau overall
Papers from B. Lau's perspective
Ordered by how strongly the researchers B. Lau trusts endorse each paper. Same corpus, a different order for every researcher.
- The Statistical Analysis of Failure Time Data (Technometrics)
- The jackknife, the bootstrap, and other resampling plans
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. (Journal of the American Medical Association (JAMA))
- Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection (Clinical Infectious Diseases)
- Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry (Journal of Virology)
- A serological assay to detect SARS-CoV-2 seroconversion in humans (medRxiv)
- Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020 (Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin)
- Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients (AIDS (London))
- Convalescent plasma as a potential therapy for COVID-19 (Lancet. Infectious Diseases (Print))
- Causal Inference Without Counterfactuals: Comment
Their papers
- Deployment of convalescent plasma for the prevention and treatment of COVID-19. (2020) — 739 citations
- Competing risk regression models for epidemiologic data. (2009) — 1,283 citations